45. Clinical utility of NGS hemeonc panel in a pediatric patient (pancytopenia concerning for primary myelofibrosis) with KRAS mutation
Application of next-generation sequencing (NGS) panels is usually limited to diagnosis, prognosis, and development of personalized treatment strategies/targeted therapies for patients with myeloid malignancies e.g., Myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), and acute myelogenous leukemia (AML). Here we present a case of 3 year old male that presented with pancytopenia and splenomegaly. His initial bone marrow revealed mild to moderate fibrosis (normocellular; no increase in blasts).
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Durga Dash, Paul L. Martin, Thomas Bennett Russel Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Genetics | Leukemia | Myelodysplastic Syndrome | Myeloproliferative Disorders | Pancytopenia | Pediatrics